• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of refractory anti-signal recognition particle myopathy using abatacept.

作者信息

Maeshima Keisuke, Kiyonaga Yasuhiro, Imada Chiharu, Iwakura Mikako, Hamasaki Hajime, Haranaka Miwa, Ishii Koji

机构信息

Department of Immunology and Rheumatology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita 879-5593, Japan.

出版信息

Rheumatology (Oxford). 2014 Feb;53(2):379-80. doi: 10.1093/rheumatology/ket251. Epub 2013 Aug 6.

DOI:10.1093/rheumatology/ket251
PMID:23920268
Abstract
摘要

相似文献

1
Successful treatment of refractory anti-signal recognition particle myopathy using abatacept.使用阿巴西普成功治疗难治性抗信号识别颗粒肌病。
Rheumatology (Oxford). 2014 Feb;53(2):379-80. doi: 10.1093/rheumatology/ket251. Epub 2013 Aug 6.
2
Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide.
Mod Rheumatol. 2014 May;24(3):529-31. doi: 10.3109/14397595.2013.852852. Epub 2014 Feb 7.
3
Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.与信号识别颗粒抗体相关的肌病：疾病进展与神经学转归
Arch Neurol. 2012 Jun;69(6):728-32. doi: 10.1001/archneurol.2011.1728.
4
Rapidly Reversible Winging Scapula.快速可逆性翼状肩胛
Arthritis Rheumatol. 2015 Sep;67(9):2502. doi: 10.1002/art.39202.
5
Anti-signal recognition particle myopathy in the first decade of life.儿童期起病的抗信号识别颗粒抗体阳性肌炎
Pediatr Neurol. 2011 Aug;45(2):114-6. doi: 10.1016/j.pediatrneurol.2011.04.009.
6
Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.与信号识别颗粒抗体相关的免疫介导坏死性肌病，采用利妥昔单抗和环磷酰胺联合治疗。
BMJ Case Rep. 2015 Aug 3;2015:bcr2014206250. doi: 10.1136/bcr-2014-206250.
7
Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.与抗信号识别肽抗体相关的肌病：临床异质性与刻板的组织病理学形成对比。
Muscle Nerve. 2007 Mar;35(3):389-95. doi: 10.1002/mus.20693.
8
A pediatric patient with myopathy associated with antibodies to a signal recognition particle.一名患有与信号识别颗粒抗体相关的肌病的儿科患者。
Brain Dev. 2012 Nov;34(10):877-80. doi: 10.1016/j.braindev.2012.02.009. Epub 2012 Mar 19.
9
Development of Necrotizing Myopathy Following Interstitial Lung Disease with Anti-signal Recognition Particle Antibody.抗信号识别颗粒抗体相关间质性肺疾病后坏死性肌病的发生
Intern Med. 2018 Jul 15;57(14):2045-2049. doi: 10.2169/internalmedicine.0303-17. Epub 2018 Feb 28.
10
Tacrolimus in combination with methotrexate and corticosteroid for the treatment of child-onset anti-signal recognition particle antibody-positive necrotizing myopathy.
Scand J Rheumatol. 2017 Sep;46(5):409-410. doi: 10.1080/03009742.2016.1241297. Epub 2016 Nov 29.

引用本文的文献

1
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial.皮下注射阿巴西普联合标准治疗方案用于活动性特发性炎性肌病的疗效与安全性：3期随机对照试验
Arthritis Rheumatol. 2025 Jun;77(6):765-776. doi: 10.1002/art.43066. Epub 2025 Feb 21.
2
Therapeutic management of immune-mediated necrotizing myositis.免疫介导性坏死性肌炎的治疗管理
Curr Treatm Opt Rheumatol. 2021 Jun;7(2):150-160. doi: 10.1007/s40674-021-00174-1. Epub 2021 Mar 29.
3
A Case of Refractory Polymyositis Successfully Treated With Abatacept Monotherapy.
1例用阿巴西普单药治疗成功的难治性多发性肌炎病例。
Arch Rheumatol. 2020 Feb 7;35(4):618-622. doi: 10.46497/ArchRheumatol.2020.7406. eCollection 2020 Dec.
4
Treatment in myositis.肌炎的治疗。
Nat Rev Rheumatol. 2018 May;14(5):279-289. doi: 10.1038/nrrheum.2018.42. Epub 2018 Mar 29.
5
Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.特发性炎性肌病（IIMs）的现代疗法：生物制剂的作用
Clin Rev Allergy Immunol. 2017 Feb;52(1):81-87. doi: 10.1007/s12016-016-8530-2.
6
Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.免疫介导性坏死性肌病：诊断与管理的最新进展
Curr Rheumatol Rep. 2015 Dec;17(12):72. doi: 10.1007/s11926-015-0548-6.
7
Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.炎症性肌病的治疗：新兴疗法与治疗靶点
Expert Rev Clin Immunol. 2015;11(11):1265-75. doi: 10.1586/1744666X.2015.1082908. Epub 2015 Aug 27.